The efficacy and safety of oral low dose naltrexone versus placebo in the patients with lichen planopilaris; a randomized controlled clinical trial.

Conclusion: Low dose naltrexone (3mg) failed to improve the severity of the LPP more than what is achievable with topical clobetasol. PMID: 32449418 [PubMed - as supplied by publisher]
Source: Journal of Dermatological Treatment - Category: Dermatology Tags: J Dermatolog Treat Source Type: research